Never before have we witnessed such a whirlwind of change in the pharmaceutical sector.
Economic downturns, the aftermath of Brexit, spiralling production costs, constricted pipelines and the voluntary scheme for branded medicines pricing and access capping (VPAS) have swirled into a bilious cocktail of pharmaceutical challenges, garnished with cautionary tales and strategic restructures.
The rapid pace of change has prompted many clients to seek our expertise to help craft sensitive internal communications. They want trusted guidance on honest and empathetic employee messaging through organisational restructures, as well as support to navigate tricky communications in challenging times.
So much change and uncertainty is prompting senior experts to act on their desires to work differently. This month we’re thrilled to introduce an ensemble of exceptional individuals who have recently joined our Collective. Adding them to our talent pool means we can support more existing and new clients with time-served experience of delivering specialist and strategic communications.
Our newest experts bring a wealth of industry wisdom, spanning the entire value chain and diverse therapeutic domains. We’re excited to explore and offer their senior expertise in critical areas like medical affairs, publications, medical education, public relations and government affairs.
Together, we’re not just adapting to change, we’re helping clients to command and drive it, guided by our Collective commitment to redefine communications excellence in the pharmaceutical landscape.
Arne Naeveke
Bringing 25 years of executive experience in all types of communications in the global biotech and biopharma industries, and in non-profit, across the entire value chain and a wide range of therapeutic areas and modalities from Aventis, Sanofi Pasteur MSD, GlaxoSmithKline (GSK), the International AIDS Vaccine Initiative (IAVI), Alexion Pharmaceuticals and Freeline Therapeutics, Arne is a trilingual (English, French and German) living in Boston, U.S. A trusted C-suite expert counsel and coach, Arne’s strong scientific background combined with sharp business acumen and journalistic credentials enable him to excel in the translation of complex matters into engaging stories.
Helen Pope
Previously holding senior positions at Four Health, Syneos and OVID, Helen spans the full spectrum of healthcare communications, from strategic consultancy and planning, campaign development, media relations, event management, disease awareness, patient activation, advisory board facilitation and outstanding project management.
Jennifer Bagnall
Driven by curiosity and a passion for well-being, Jennifer strives to find the ‘aha’ moment that drives productive connections to devise actionable pharmaceutical brand strategies. Jennifer has led teams in creative and medical communication agencies, directed market access and public relations activities, and worked in client marketing teams. Drawing on her experience in brand management consulting, medical education, advertising and DTC promotion in the US, Jennifer brings a holistic approach to problem-solving.
Olivia Keegan
Bringing a background in evidence-based medical communications and strategic partnerships, Olivia applies behaviour change strategies to educational programmes. With her strong scientific understanding, Olivia has designed, delivered and led strategic medical programmes for global pharmaceutical companies across a range of therapy areas, including HIV, oncology, ophthalmology, cardiovascular, hepatology, and cell therapy. She has also led organisation-wide transformation projects during her time within Gilead’s Medical Affairs team.
Paula Hensler
A dedicated and versatile scientific communications consultant, Paula provides senior strategic counsel to pharmaceutical and biotech clients with a focus on translating complex data and concepts into targeted content and tactics that challenge behaviours and beliefs. Working across medical affairs, publications, medical education and PR, Paula’s vast therapeutic expertise includes immunology, dermatology, oncology, haematology, HIV, neurology and cardiology whilst being passionate about rare and ultra-rare diseases and improving patient outcomes through omnichannel programmes.
Rachel Gonzaga
Passionate about campaigning and creating change to improve the lives of patients, Rachel’s extensive background in healthcare communications spans internal and external communications and patient advocacy roles at OVID Health, GSK and Cancer Research UK.
About The Difference Collective
The Difference Collective is a team of outstanding senior healthcare communicators, purpose-built around client needs, delivering exceptional results by taking a Different and highly responsive approach. The Difference Collective brings together talented, driven, top-flight independent consultants with stellar track records and specialist expertise, to give clients exactly the resources they need, when they need them.
Please get in touch – we’d love to talk about how best to work with you.
